deJipidified cell components of My cobacterium /eprae (DeC) and Dharmendra lepromin. Dharmendra lepromin was poor in inducing in vitro T cell proliferation in all the study groups, even though it elicited marked in vivo skin test reaction in tuberculoid leprosy patients and healthy contacts. In contrast, Dharmendra preparation of BeG induced marked T-cell response in tuberculoid as well as bacterial index negative lepromatous patients. Dee induced a significantly higher lymphoproliferative response than Dharmendra lepromin in all study groups. A significant positive correlation was observed between the Iymphoproliferative responses to Dee and BeG. The present study, based on a large number of leprosy patients and healthy contacts, clearly demonstrates that Dee, depleted of glycolipids and lipopolysaccharides, is a good antigenic preparation for evaluat ing T-cell reactivity to M. leprae.
Although leprosy continues to be a major public health problem in many parts of the world, I WHO envisages that vigorous implementation of multidrug chemotherapy will decrease the prevalence of the disease to a negligible level by the year 2000;2 also research to develop an antileprosy vaccine that wi i l interrupt the transmission of the disease is being vigorously carried out. 3 Most individuals in leprosy-endemic areas develop a strong cellular immunity to Mycobacterium leprae and do not develop the disease,3,4 and only a small minority become susceptible to the infection, and the reasons for their fa ilure to develop a protective immunity against M. leprae are poorly understood.5•6 An ideal antileprosy vaccine must be capable of inducing protective immunity against M. leprae in these individuals. 3 Prospective antileprosy vaccines, such as killed M. leprae and BCG, either alone or in combination, and 2 other closely-related mycobacteria, namely ICRC bacillus and Mycobacterium w, are currently undergoing field trials.7 These vaccines were initially selected for their immunotherapeutic potential in leprosy patients before being used for clinical trials in apparently healthy individuals in a leprosy-endemic population. 3 Many studies have demonstrated that M. leprae inhibits T-cell responses both in vitro and in vivo.7-1 5 Certain cell surface components of M. leprae, such as phenolic glycolipid-I (PGL-I), Iipoarabinomannan (LAM) and lipopolysaccharide, were shown to inhibit T lymphocyte proliferation l 5-19 as well as interferon-y (IFN-y)-mediated activation of macrophages20-22 in vitro. However, because it is not known how these immunomodu latory components of M. leprae in the vaccine preparations would influence the development of immunity to leprosy fo llowing vaccination, attempts have been made to remove these inhibitory substances from M. lep rae to render it more immunogenic. Several studies have demonstrated that cell walls of M. leprae depleted of lipids, glycolipids and carbohydrate antigens induced strong T-cell proliferative responses,23-27 induced IL-2 and IFN-y synthesis,28 augmented the killing of phagocytosed live M. leprae inside the macrophages,29 elicited pronounced delayed type hypersensitivity reactions in sensitized guinea-pigs and tuberculoid leprosy patients,27 and protected mice against leprosy bacilli. 30
In this study, we evaluated the antigenicity of delipidified cell components of M. leprae (DCC, referred to previously as delipidified cell waH, DCW) by measuring the in vitro T lymphocyte reactivity to this in a large number of healthy contacts and leprosy patients across the disease spectrum, taken from a leprosy-endemic population in southern India. For comparison, the Iymphoproliferative response to BCG and Dharmendra lepromin and the skin test reaction to the latter were also simultaneously measured.
Materials and methods

ANTIGENS
The Dharmendra preparation of M. leprae was generously supplied by Dr U. Sengupta, Central lalma Institute for Leprosy, Agra, India. The BCG (Danish strain 1331) was kindly provided by The Director, BCG Vaccine Laboratories, Madras, India. It was subjected to Dharmendra treatment31 and suspended in phosphate-buffered saline at a concentration of 107 baciHi per m\. Delipidified cell components of M. leprae (DCC) were prepared as described previously.24 (Briefly, the pellet fraction of M. /eprae sonicate extract was washed 3 times with chloroform : methanol (2 : 1). The residual material was fu rther delipidified by extensive treatment with acetone and then with ethanol : ether (1 : 1). The final residue was suspended in saline and the protein concentration was determined.) Metrizoate sodium, Hanks's balanced salt solution, powdered culture medium, RPM I 1640 and penicillin-streptomycin mixture were purchased from Sigma Chemical Co., USA. Ficoll 400 was purchased from Pharmacia, Sweden.
BLOOD SAMPLES
Blood samples from leprosy patients, healthy family contacts (HFC) and healthy hospital contacts (HHC) were collected from a leposy hospital (Voluntary Health Services, Leprosy Project) located at Sakthinagar in the Periyar District, Tamil Nadu, India. The population covered by this leprosy control unit had a prevalence rate of 15·32 per 1000 at the beginning of this study (April 1989) and is covered by multidrug chemotherapy. Leprosy patients were classified clinically and bacteriologically3 2 into polar lepromatous (LL), borderline lepromatous (BL), mid borderline (BB), borderline tuberculoid (BT) and polar tuberculoid (TT) patients. HFC were healthy individuals living in the household of leprosy patients. Healthy hospital staff who had been exposed to leprosy patients for between 1 and 10 years were classified as HHC. We studied 162 samples, which had been collected from 96 leprosy patients (33 LL, 13 BL, II BB, 27 BT and 12 TT), 52 HFC and 14 HHC. Untreated and treated patients, under MDT for between 2 and 228 weeks, were included. LL and BL patients were grouped together and segregated into bacterial index (BI) positive (LBI +) and BI negative (LBI -) lepromatous patients. Patients with reactions were excluded from this study. We took 16 healthy noncontact (HNC) samples from students of the School of Biological Sciences, Madurai Kamaraj University, who had not had any habitual contact with leprosy patients even though they live in an endemic area. The study subjects were selected randomly without any bias towards age or sex. However, individuals below 12 years and above 70 years of age were not included. Each subject donated about 20 ml of venous blood into heparinized vacutainers (Vacuette; Griener, Germany).
L YMPHOPROLIFERA TIVE ASSAYS
Peripheral blood mononuclear cells (PBMC), separated over a Ficoll-metrizoate density gradient,33 were washed and suspended at a concentration of I x 106jml in RPMI 1640 containing penicillin (100 Ujml), streptomycin (100 ,ugjml) and 10% foetal calf serum (FCS) or normal human AB serum. Cultures with 105 cells in 200 ,ul final volume were stimulated with optimal concentration of PHA-P (10 ,ugjml), Dharmendra lepromin (5 x 105 bacilli per ml), DCC (10 ,ugjml) or BCG (5 x 105 bacillijml). The antigens are not cytotoxic at the concentrations used. Triplicate cultures in 96 well flat-bottom microtitre plates (Nunc, Denmark) were incubated at 37°C in a humidified atmosphere of 5% CO 2 -95% air. Mitogen cultures were stimulated in FCS-containing medium for 3 days while antigen cultures were stimulated in human AB serum containing medium for 6 days. During the final 16 hr of the culture period, 0·5 ,uCi of 3H-thymidine (Bhabha Atomic Research Center, Bombay, India, specific activity 6·7 Cijmmol) was added to each well. Cultures were harvested onto glass fibre filters and the radioactivity incorporated was measured by a liquid scintillation counter (LKB Wallac, Sweden).
The results are expressed as �CPM (mean CPM of stimulated cultures -mean CPM of control cultures) or stimulation index (SI = mean CPM of stimulated cultures/mean CPM of control cultures). Based on the range of response observed and the published literature, responses were considered positive when the SI was more than 3·0 and ilCPM was more than 5000 for all antigens, and was more than 10,000 for PHA-P.
LEPROMIN SKIN TEST
A lepromin skin test was performed on the same day that blood samples were collected for Iymphoproliferative assays. Indurations developed in response to intradermally inocu lated Dharmendra lepromin (0' 1 ml) were recorded 21 days postinoculation (late lepromin reaction).
STATISTICAL ANALYSIS
The Student's t-test and regression analyses were carried out using the EPISTAT statistical package.
Results
L YMPHOPROLIFERA TIVE RESPONSE
PBMC from all groups of leprosy patients, healthy contacts and noncontacts showed poor in vitro proliferative response to Dharmendra lepromin ( Table 1 ). None of the lepromatous patients responded to Dharmendra lepromin and, even in the other study groups only a small proportion of individuals showed any responsiveness ( Figure I ). On the other hand, DCC induced a markedly higher proliferative response than Dharmendra lepromin in all the study groups ( Table I) . Discernible gradation was observed in the proportion of responders to DCC, increasing from the lepromatous to tuberculoid pole ( Figure I ). Such a gradation was not observed for the mitogenic response to PHA-P, which was uniformly high among the various study groups, including the lepromatous patient groups. Proportion of responders to PHA-P, Dharmendra lepromin, DCC and Dharmendra preparation of BCG in in vitro Iymphoproliferative assays. Responses were considered positive when SI was more than 3·0 and �CPM values were more than 10,000 for PHA-P and more than 5,000 for all antigens.
In contrast to Dharmendra lepromin, Dharmendra preparation of BCG induced good proliferative response in all groups of leprosy patients, contacts and noncontacts ( Table I) . HNC showed significantly higher responses than all the other study groups. Interestingly, the proportion of BCG responders was significantly higher among LBI patients than LBI + patients ( Figure I ). It should be noted that responses to DCC and BCG were markedly low among HFC compared to HHC, while their responses to PHA-P were comparable ( Table I) .
Analysis of the pooled data from all study groups revealed a significant positive correlation between the responses to DCC and BCG (Figure 2 ). Almost all responders to DCC responded to BCG as well (45/51). About 40 % of the subjects did not respond to both DCC and BCG, and the majority of these individuals belonged to lepromatous and BB patients (Table 2) . A considerable proportion of HFC also failed to respond to both. In contrast, the majority of the HHC responded to both the antigens. Strikingly, 23 out of 3  33  67  0  0  BB  9  22  22  II  45  BT/TT  9  56  22  0  22  HFC  47  30  23  2  45  HHC  14  64  14  22  0  HNC  II  82  18 .. ' ..
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BC G ( l::. CPM X 10 -4 ) Figure 2 . Correlation between the responses to DCC and BCG. Data from all leprosy patient groups, healthy contacts and noncontacts were pooled and the correlation between the responses to DCC and BCG was evaluated by regression analysis. Vertical and horizontal dashed lines bisecting the x and y axes represent the cutoff values for positive response to BCG and DCC, respectively (for details see Fig. I ). For each plot, the number and the percentage (in parentheses) of individuals within each quadrant are mentioned. r, correlation coefficient; n, total number of subjects studied; p, significance level of the correlation. We inoculated 0· 1 ml of Dharmendra lepromin intradermally in the forearm. The induration was measured after 21 days. Based on the diameter of induration, scores are defined arbitrarily. Skin testing was not done on healthy noncontacts. 68 BCG responders did not respond to DCC (Figure 2 ) and these subjects were represented in all groups of leprosy patients, HFC, HHC and HNC (Table 2 ).
IN VI VO SKIN TEST REACTION TO DHARMENDRA LEPROMIN
Despite its fa ilure to induce in vitro lymphoproliferative response uniformly in all groups of leprosy patients and healthy controls, Dharmendra lepromin elicited a marked late lepromin reaction in tuberculoid patients and healthy contacts (Table 3) . Lepromatous * N = Number of individuals tested in each group. Responders (R) and nonresponders (NR) are defined in Table 3 and Figure I .
patients, irrespective of their BI status, and BB patients did not develop a skin test reaction to Dharmendra lepromin.
Analysis of the data revealed that in a considerable proportion of individuals among all study groups (except TT) who fa iled to mount lepromin reaction in vivo, DCC elicited a positive lymphoproliferative response (Table 4 ). Conversely, among tuberculoid patients and healthy contacts a significant proportion of individuals did not respond to DCC in vitro, but developed a lepromin reaction in vivo.
Discussion
Various preparations of M. leprae, such as whole bacilli, Dharmendra lepromin, sonicate extracts and cell wall components have been used in in vitro assays to measure T lymphocyte reactivity to the antigens of M. /eprae in leprosy patients and healthy contacts.9,34-38 Recent investigations have demonstrated that PGL-I and LAM which accumulate on the surface of M. leprae are the major immunomodulatory components capable of inhibiting both T cell proliferation 16-19 and macrophage activation and effector functions.2o,21 In fact, LAM has been shown to inhibit the transcription of IL-2 gene in T lymphocytes39 and IFN-y inducible genes in mononuclear phagocytes.4o Most individuals exposed to leprosy bacilli in endemic areas overcome the adverse effects of these components and develop strong cellular immune responses and protective immunity to the pathogen.
In the present study involving a large number ofieprosy patients and healthy contacts, we observed that Dharmendra lepromin induced poor in vitro lymphoproliferation in all study groups though others have shown reactivity in tuberculoid patients and healthy contacts.9,34 In contrast, Dharmendra preparation of BCG induced proliferation of PBMC from all groups including the BI negative lepromatous patients, indicating that Dharmendra treatment31 of mycobacteria by chloroform and ether per se does not affect the antigenic constituents. The fact that Dharmendra lepromin induced marked skin test reactions in tuberculoid patients and healthy contacts argues against any loss of antigenic material in the preparation, as well as against the lack of immunological reactivity in the study subjects towards M. /ep rae. Earlier studies from our laboratory have demonstrated that Dharmendra lepromin inhibited T cell proliferative responses of normal subjects to mitogens and antigens, and this was associated with the downregulation of CD2 expression on T lymphocyte surface. 1 3• 14 However, DCC did not modulate CD2. 41 Presumably, the immunomodulatory components of M. /eprae present in Dharmendra lepromin would obscure the stimulatory effect of its antigenic constituents. In contrast to Dharmendra lepromin, whole bacilli have been shown to elicit a T cell proliferative response in tuberculoid patients.35 Therefore, it is likely that the immunomodulatory components are more exposed on Dharmendra lepromin than whole bacilli by limited treatment with organic solvents. However, induction of marked skin test reactions by Dharmendra lepromin suggests that the immunomodulatory components are either diluted out or degraded in vivo, and the antigenic components released slowly from the intact bacilli elicit a strong late lepromin reaction. DCC induced a significantly higher level of Iymphoproliferative response than Dharmendra lepromin in all groups of leprosy patients, healthy contacts and non contacts. A significant positive correlation observed between the responses to DCC and BCG reflects the close antigenic similarity between M. /eprae and M. bovis BCG. However, about 20% of the subjects belonging to all study groups responded to BCG but not to DCC, indicating that responsiveness to BCG is not always associated with a positive response to DCC. This is probably due to the qualitative and quantitative differences in the antigenic composition of DCC and BCG, as much as the variability in the immune response of an individual.
Our results show that DCC is indeed a better antigenic preparation than Dharmendra lepromin for measuring the T lymphocyte response to M. /eprae. In fact, DCC induced a Iymphoproliferative response even in those individuals who failed to show an in vivo skin test reaction to Dharmendra lepromin. On the other hand, a positive skin-test response to Dharmendra lepromin in the absence of demonstrable T cell reactivity to DCC in vitro could be explained by a very low frequency ofT lymphocytes reactive to M. leprae in the peripheral circulation which could have been recruited to the inoculation site over the period of 21 days. It has also been demonstrated that purified cell wall preparations of M. /ep rae induced more pronounced skin test reactions than lepromin in tuberculoid leprosy patients.27 Depletion of lipids and carbohydrates has rendered DCC more antigenic, presumably by relieving the immunomodulatory effects on antigen-presenting macro phages and effector T lymphocytes. Though the immunomodulatory components present in whole M. leprae preparations used for vaccination are likely to be cleared by catabolic processes, they can delay the induction of specific immunity, especially at doses given for vaccination compared to that used for skin testing. Therefore, until the immunogenic constituents of M. leprae are defined at molecular level, delipidified antigenic prepara tions of M. leprae would be ideal alternatives to whole bacilli in leprosy vaccination strategies.
Reactivite aux constituants cellulaires delipidifies de My cobacterium leprae des Tlymphocytes de malades lepreux et de contacts sains appartenant a une population 00 la lepre est endemique
Resume Nous avons mesure la proliferation in vitro des mononucIeaires du sang peripherique en reponse a la presence des constituants cellulaires delipidifies de Mycobacterium /eprae (DCC) et de la lepromine Dharmendra chez, d'une part, des lepreux choisis dans tout Ie spectre cIinique et, d'autre part, des contacts sains pris dans une population ou la lepre est endemique. La lepromine Dharmendra a provoque une mediocre proliferation des cellules T in vitro dans to us les groupes de l'etude, bien qu'elle ait suscite in vivo une reaction nette au test cutane dans les cas de lepre tuberculolde et chez les contacts sains. Par contre, la preparation Dharmendra de BCG a provoque une reponse nette des cellules T tant chez les malades lepromateux tuberculoldes que chez ceux a indice bacteriel negatif. DCC a provoque une Iymphoproliferation significativement plus elevee que la lepromine Dharmendra chez to us les groupes de I'etude. Nous avons observe une correlation positive significative entre les reponses a DCC et BCG. Cette etude, basee sur un grand nombre de malades lepreux et de contacts sains demontre cIairement que DCC, apres elimination des glycolipides et des lipopolysaccharides, constitue une bonne preparation antigenique pour evaluer la reactivite des cellules T a M. /eprae.
La reactividad de T Linfocitos de los pacientes leprosos y contactos sanos de poblaciones con lepra endemic a, a los componentes de celulas delipidificadas de My cobacterium leprae Resumen En este estudio, se midieron las respuestas proliferatives de las celulas mononucIeares hematicas perifericas tanto de los pacientes leprosos con una extensa gama clinica, como de los contactos sanos de poblaciones con lepra endemica, a los componentes de celulas delipidificadas de Mycobacterium /eprae (DCC) y Dharmendra lepromin. EI Dharmendra lepromin tenia poca efectividad para inducir proliferacion de celulas T in vitro en todos los grupos estudiados, aunque provoco una reaccion dermica in vivo en los leprosos tuberculoides y en los contactos sanos. En cambio, la preparacion Dharmendra de BCG inducio una respuesta definitiva de celulas T en los pacientes tuberculosos ademas de en los pacientes lepromatosos con indice bacteria no negativo. Dee inducio una respuesta lainfoproliferativa significativamente mayor que el Dharmendra lepromin en todos los grupos estudiados. Se observo una correlacion positiva significativa entre las respuestas linfoprolifertivas al DCC y el BCG. Este estudio, basado en un gran numero de leprosos y contactos san os, demuestra clara mente que DeC, con reducido glicolipidos y lipopolisacaridos, es una buena preparacion antigenica para la evaluacion de la reactividad de celulas TaM . /eprae.
